Search

Author/Creator Fracchiolla, N.

1. Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy. (April 2023)

Authors:
Maurillo, L.; Spagnoli, A.; Candoni, A.; Papayannidis, C.; Borlenghi, E.; Lazzarotto, D.; Fianchi, L.; Sciumè, M.; Zannier, M.E.; Buccisano, F.; Del Principe, M.I.; Mancini, V.; Breccia, M.; Fanin, R.; Todisco, E.; Lunghi, M.; Palmieri, R.; Fracchiolla, N.; Musto, P.; Rossi, G.
Journal:
Leukemia research
Issue:
Volume 127(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Fungal infections of the central nervous system and paranasal sinuses in onco‐haematologic patients. Epidemiological study reporting the diagnostic‐therapeutic approach and outcome in 89 cases. Issue 3 (22nd January 2019)

Authors:
Candoni, A.; Klimko, N.; Busca, A.; Di Blasi, R.; Shadrivova, O.; Cesaro, S.; Zannier, M. E.; Verga, L.; Forghieri, F.; Calore, E.; Nadali, G.; Simonetti, E.; Muggeo, P.; Quinto, A.M.; Castagnola, C.; Cellini, M.; Del Principe, M.I.; Fracchiolla, N.; Melillo, L.; Piedimonte, M.
Journal:
Mycoses
Issue:
Volume 62:Issue 3(2019)
Page Start:
252
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P307: DEL(17)(Q11) IS TYPICAL MARKER OF IMMATURE T-ALL OF ADULTS, WITH NF1, UTP6, AND SUZ12 HAPLOINSUFFICIENCY, GENOME INSTABILITY, AND GENE DOWNREGULATION. (23rd June 2022)

Authors:
Bardelli, V.; Pierini, V.; Arniani, S.; Mvridou, E.; Matteucci, C.; Lema Fernandez, A. G.; Moretti, M.; Elia, L.; Giglio, F.; Forghieri, F.; Cerrano, M.; Fracchiolla, N.; Delia, M.; Sica, S.; Mecucci, C.; La Starza, R.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
208
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P353: FORTY MONTHS UPDATE OF THE GIMEMA LAL2116 (D-ALBA) PROTOCOL AND ANCILLARY LAL2217 STUDY FOR NEWLY DIAGNOSED ADULT PH+ ALL. (23rd June 2022)

Authors:
Chiaretti, S.; Bassan, R.; Vitale, A.; Elia, L.; Piciocchi, A.; Viero, P.; Ferrara, F.; Lunghi, M.; Fabbiano, F.; Bonifacio, M.; Fracchiolla, N.; Di Bartolomeo, P.; Fazi, P.; De Propris, M. S.; Vignetti, M.; Guarini, A.; Rambaldi, A.; Foà, R.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
253
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P357: MULTICENTER RETROSPECTIVE ANALYSIS OF CLINICAL OUTCOME OF ADULT PATIENS WITH MIXED-PHENOTYPE ACUTE LEUKEMIA (MPAL) DIAGNOSED AND TREATED IN THE LAST TEN YEARS. A CAMPUS-ALL STUDY. (23rd June 2022)

Authors:
Lazzarotto, D.; Tanasi, I.; Vitale, A.; Piccini, M.; Dargenio, M.; Giglio, F.; Forghieri, F.; Fracchiolla, N.; Cerrano, M.; Todisco, E.; Papayannidis, C.; Leoncin, M.; Defina, M.; Guolo, F.; Pasciolla, C.; Delia, M.; Chiusolo, P.; Mulè, A.; Candoni, A.; Bonifacio, M.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
257
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. S113: NATIONAL PEGASPARGASE-MODIFIED RISK-ORIENTED PROGRAM FOR PHILADELPHIA-NEGATIVE ADULT ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA (PH− ALL/LL). GIMEMA LAL 1913 FINAL RESULTS. (23rd June 2022)

Authors:
Bassan, R.; Chiaretti, S.; Della Starza, I.; Spinelli, O.; Santoro, A.; Elia, L.; De Propris, M. S.; Scattolin, A. M.; Paoloni, F.; Messina, M.; Audisio, E.; Marbello, L.; Borlenghi, E.; Zappasodi, P.; Vetro, C.; Martinelli, G.; Mattei, D.; Fracchiolla, N.; Bocchia, M.; De Fabritiis, P.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
14
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search